about
Identification of a potent endothelium-derived angiogenic factorIdentification and quantification of diadenosine polyphosphate concentrations in human plasma.Mass-spectrometric identification of a novel angiotensin peptide in human plasma.Isoforms of retinol binding protein 4 (RBP4) are increased in chronic diseases of the kidney but not of the liverAlterations of retinol-binding protein 4 species in patients with different stages of chronic kidney disease and their relation to lipid parameters.Association of versican turnover with all-cause mortality in patients on haemodialysis.Urinary calprotectin and posttransplant renal allograft injury.The renal arterial resistive index and stage of chronic kidney disease in patients with renal allograft.N-Acetylcysteine in the prevention of ototoxicity.Interleukin-8 transcripts in mononuclear cells determine impaired graft function after kidney transplantation.The 82-plex plasma protein signature that predicts increasing inflammation.Contrast medium-induced nephropathy: the pathophysiology.Role of leptin in reverse epidemiology in chronic kidney disease.Increased rhythmicity in hypertensive arterial smooth muscle is linked to transient receptor potential canonical channels.The role of transient receptor potential channels in metabolic syndrome.Activation of TRPV1 by dietary capsaicin improves endothelium-dependent vasorelaxation and prevents hypertension.Transient receptor potential canonical type 3 channels--their evolving role in hypertension and its related complications.Expression of the NRF2 Target Gene NQO1 Is Enhanced in Mononuclear Cells in Human Chronic Kidney Disease.Insulin Increases Expression of TRPC6 Channels in Podocytes by a Calcineurin-Dependent Pathway.Dialysis for twins.Lower Superoxide Dismutase 2 (SOD2) Protein Content in Mononuclear Cells Is Associated with Better Survival in Patients with Hemodialysis Therapy.Increased arterial vascular tone during the night in patients with essential hypertension.Factors predicting kidney damage in Puumala virus infected patients in Southern Denmark.Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis.Continuous reduction of plasma paraoxonase activity with increasing dialysis vintage in hemodialysis patients.Green urine following exposure to flupirtine.Decreased expression of transient receptor potential channels in cerebral vascular tissue from patients after hypertensive intracerebral hemorrhage.Nonoxidized, biologically active parathyroid hormone determines mortality in hemodialysis patients.Superoxide dismutase type 1 in monocytes of chronic kidney disease patients.Increased transient receptor potential canonical type 3 channels in vasculature from hypertensive rats.Does prophylactic haemodialysis protect kidney function after angiography?Modulation of NADPH oxidase activity by known uraemic retention solutes.High glucose modifies transient receptor potential canonical type 6 channels via increased oxidative stress and syndecan-4 in human podocytes.High-sensitivity C-reactive protein predicts target organ damage in Chinese patients with metabolic syndrome.Monocytes from spontaneously hypertensive rats show increased store-operated and second messenger-operated calcium influx mediated by transient receptor potential canonical Type 3 channels.Urinary endotrophin predicts disease progression in patients with chronic kidney disease.Modeling of oxidized PTH (oxPTH) and non-oxidized PTH (n-oxPTH) receptor binding and relationship of oxidized to non-oxidized PTH in children with chronic renal failure, adult patients on hemodialysis and kidney transplant recipients.Sleep is more than a break from life.[Role of transient receptor potential channels in the cardiovascular system]Functional transient receptor potential vanilloid 1 and transient receptor potential vanilloid 4 channels along different segments of the renal vasculature.
P50
Q28534947-551D550B-F6C0-43CE-ABFE-21F2AEC18579Q30927467-D645D272-2633-4F61-9AD6-519B760B5E80Q33265175-F45C7925-FCBE-4B0D-95FB-C434EA7C8C73Q33364279-DC547CCA-A8BC-4C44-A18A-EABEDAC42EF1Q33526141-5111F04C-DED2-48E8-AAF0-8291664C8BC9Q34420828-F05F8DAD-F5C4-4D93-9B1B-85D7D754A004Q34525420-7AC11CA2-DE10-46BD-BABF-10DD83129DE8Q34525654-E2A633A5-6320-4051-95CC-25BB66F94A78Q34655934-77241CAF-ED29-4318-9144-0E5D5F482F7AQ35091544-7AE6AA8C-D54F-465B-8B11-B8E90E43F109Q36134230-97EAE2C7-64DC-4E53-B81B-8ED087645B72Q36448323-F36AD81F-DE5A-4038-AF4E-33E589F89ED5Q36996687-E8060DF1-B046-49CF-A9D4-E686B13E0F99Q37295391-FA6FEE4D-53FB-4343-9EFE-E36FDE8EB26CQ37355501-05B2E218-798E-4500-846A-122D31C6F97CQ37532402-783F0525-6337-47F7-BCF7-87E8DA350799Q38077920-4EE7C1D8-6BF3-400B-BFEC-D8EEF4DEC20EQ38635855-AA81EA7D-1F52-4A8E-9888-D0AF028FD827Q38796229-9ADBB30F-CA05-44BC-B86F-9626E1BC3547Q39369633-6E80B451-7891-4238-8206-F69AA522FEC2Q39388008-17AF00A8-CE63-4A78-A8DE-24A15767C372Q39770819-DBD9CE46-1E22-4886-8699-7B599CFE7FC6Q40146013-C9E56C22-9C5B-4076-999B-701243EDAA6AQ42726923-D008EF47-BA13-41E1-9388-5F1F57D86857Q42789860-B9DD9D25-E485-407A-AF1A-0699437655F1Q42849850-0333606B-6D45-46F1-A9C5-165FE980F489Q43798845-CCD25DF5-237E-4DA4-9AD3-6007BDE5EA86Q44451027-00EDAE85-57F3-42BA-86DC-D064900AF6D1Q45916695-EF0DFD67-774C-436F-8F6B-85EB1D0E2F77Q46231212-080FB925-3B4A-4DE5-B7DC-E6659AE8EE5BQ46786449-CA612D01-1AF6-49A5-8DE6-F9481C1E14AEQ46864424-74A543F8-0D8B-4BB9-9E25-F770CF15AF2AQ46877648-DAD2CCC0-C5C9-4A22-A460-410CE62C66E5Q46903468-F52E7D41-2E7D-4432-8D60-96494C52649BQ46975912-D1729624-C568-4371-B8BC-620A4FEFB7E5Q47111536-A888F911-9A2F-46D2-8FCE-B58A44FBC5EFQ47980389-3E2599E8-E35E-46CE-B34E-2F8471B27F38Q48506040-6F2BA202-CD23-4A13-B41C-26BDEC663EBBQ52685218-A9F55062-9C8B-45B3-BC55-D7293201EC3AQ52875001-7112EBEF-B947-4A36-9BF2-0C27F94E7D35
P50
description
researcher
@en
wetenschapper
@nl
name
Martin Tepel
@en
Martin Tepel
@nl
type
label
Martin Tepel
@en
Martin Tepel
@nl
prefLabel
Martin Tepel
@en
Martin Tepel
@nl
P106
P31
P496
0000-0002-0086-0997